These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


45 related items for PubMed ID: 2447413

  • 1. New antianginal therapy. First International Symposium on Nicorandil, a new antianginal agent. Honolulu, Hawaii, U.S.A, January 24-26, 1986.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S1-129. PubMed ID: 2447413
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of nicorandil on coronary circulation in patients with ischemic heart disease: comparison with nitroglycerin.
    Aizawa T, Ogasawara K, Kato K.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S123-9. PubMed ID: 2447419
    [Abstract] [Full Text] [Related]

  • 8. Similarity and dissimilarity in the mode and mechanism of action between nicorandil and classical nitrates: an overview.
    Taira N.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S1-9. PubMed ID: 2447414
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The mechanism of inhibitory effects of nicorandil, a new antianginal agent, on contractile responses to alpha 1- and alpha 2-adrenoceptor agonists in isolated vascular smooth muscles.
    Satake N, Shibata S.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S38-43. PubMed ID: 2447423
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Protective effects of the antianginal agent nicorandil on arachidonate-induced sudden death in rats: comparison with several antianginal agents and cyclooxygenase inhibitors.
    Sakai K, Yamazaki T, Nakamura Y, Sugimoto T.
    Jpn J Pharmacol; 1985 Jan; 37(1):124-8. PubMed ID: 3157816
    [Abstract] [Full Text] [Related]

  • 14. Effects of nicorandil on large epicardial coronary artery in conscious dogs.
    Yamada A, Tomoike H, Hayashi Y, Nishijima H, Nakamura M.
    Arzneimittelforschung; 1987 Nov; 37(11):1252-5. PubMed ID: 2964242
    [Abstract] [Full Text] [Related]

  • 15. Angiographic response to a vasodilating drug, nicorandil, in patients with coronary artery disease.
    Kishida H, Hata N, Kusama Y, Iwahara S, Sasaki Y, Mori N, Yasutake M, Koumi S, Takayama M, Munakata K.
    Jpn Heart J; 1990 Mar; 31(2):135-43. PubMed ID: 2141366
    [Abstract] [Full Text] [Related]

  • 16. Vasodilative effect of nicorandil on coronary artery.
    Miyazaki Y, Ogawa K, Satake T, Sugiyama S, Ozawa T.
    Arzneimittelforschung; 1985 Mar; 35(2):504-7. PubMed ID: 3158319
    [Abstract] [Full Text] [Related]

  • 17. [Nicorandil, a potassium channel agonist].
    Gerson C.
    Soins; 1996 Nov; (610):61. PubMed ID: 9016185
    [No Abstract] [Full Text] [Related]

  • 18. Coronary vasodilatory action after nicorandil: a quantitative angiographic study.
    Suryapranata H, Serruys PW.
    Am J Cardiol; 1989 Jun 20; 63(21):80J-85J. PubMed ID: 2525332
    [Abstract] [Full Text] [Related]

  • 19. [Potassium channel activators: hemodynamic effects at the systemic and coronary level].
    Perrone Filardi P, Chiariello M.
    Cardiologia; 1995 Dec 20; 40(12 Suppl 1):87-9. PubMed ID: 8998787
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.